A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on: February 23,2024

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on:February 23,2024

Shades of grey reveal breast tumours

by David Bradley,InderscienceMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast cancer is the second most common cancer in women. Mammography

Updated on: March 01,2024

Shades of grey reveal breast tumours

by David Bradley,InderscienceMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast cancer is the second most common cancer in women. Mammography

Updated on:March 01,2024

Research examines how to stay on task

by University of Texas at ArlingtonTask paradigm visual for a single trial on the four-choice reaction time task. Credit:Attention, Perception, & Psychophysics(2023). DOI: 10.3758

Updated on: March 12,2024

Research examines how to stay on task

by University of Texas at ArlingtonTask paradigm visual for a single trial on the four-choice reaction time task. Credit:Attention, Perception, & Psychophysics(2023). DOI: 10.3758

Updated on:March 12,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on: March 06,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on:March 06,2024

The hitchhiker's guide to defeating glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In cancer therapeutics research, microRNAs—tiny strings of nucleotides that get churned out inside

Updated on: April 18,2024

The hitchhiker's guide to defeating glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In cancer therapeutics research, microRNAs—tiny strings of nucleotides that get churned out inside

Updated on:April 18,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on: January 30,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on:January 30,2024

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on: March 12,2024

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on:March 12,2024

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on: January 30,2024

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on:January 30,2024

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d

Updated on: March 12,2024

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d

Updated on:March 12,2024

Care at high-volume radiation treatment centers tied to higher survival

by Lori SolomonAmong men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug.

Updated on: February 01,2024

Care at high-volume radiation treatment centers tied to higher survival

by Lori SolomonAmong men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug.

Updated on:February 01,2024

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on: February 18,2024

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on:February 18,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on: May 31,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on:May 31,2024